Literature DB >> 26122532

Headache and Pain in Guillain-Barré Syndrome.

Constantine Farmakidis1, Seniha Inan, Mark Milstein, Steven Herskovitz.   

Abstract

While moderate and severe back or extremity pain is frequent in Guillain-Barré syndrome (GBS), headache appears to be uncommon. Most of the reports of headache in GBS place it in the context of the posterior reversible encephalopathy syndrome (PRES) which is increasingly recognized as a likely dysautonomia-related GBS complication. There are also a few reports of headache in the setting of increased CSF pressure and papilledema and in association with the Miller Fisher GBS variant. In comparison, back and extremity pain is highly prevalent. Aching muscle pain and neuropathic pain are the two most common of several pain types. Pain may be a heralding feature and has been described in patients as long as 2 years after disease onset. Pain management is a major axis of treatment in GBS. Gabapentin is a reasonable first-line choice, and opioid medications can be added for more severe pain but there are few clinical trials to inform specific recommendations. While the understanding of pain pathophysiology in GBS is incomplete, its prevalence and clinical impact are increasingly recognized and studied. Pain should be considered a cardinal manifestation of GBS along with acute, mostly symmetric weakness and diminished reflexes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122532     DOI: 10.1007/s11916-015-0508-x

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  57 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Reversible cerebral vasoconstriction in Guillain-Barré syndrome.

Authors:  Diana Y Wei; Justin Kao; Teddy Y Wu; Jennifer A Pereira; Neil E Anderson; P Alan Barber
Journal:  J Clin Neurosci       Date:  2015-03-13       Impact factor: 1.961

4.  Pain due to peripheral nerve damage: an hypothesis.

Authors:  A K Asbury; H L Fields
Journal:  Neurology       Date:  1984-12       Impact factor: 9.910

Review 5.  Posterior reversible encephalopathy syndrome in Guillain-Barré syndrome.

Authors:  Adam Chen; Jennifer Kim; Galen Henderson; Aaron Berkowitz
Journal:  J Clin Neurosci       Date:  2015-03-20       Impact factor: 1.961

6.  Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin.

Authors:  R Voltz; F V Rosen; T Yousry; J Beck; R Hohlfeld
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

7.  Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome.

Authors:  Vivian E Drory; Tanja Bronipolsky; Vadim Bluvshtein; Amiram Catz; Amos D Korczyn
Journal:  J Neurol Sci       Date:  2012-02-14       Impact factor: 3.181

8.  Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.

Authors:  Reiko Koichihara; Shin-Ichiro Hamano; Shintaro Yamashita; Manabu Tanaka
Journal:  Pediatr Neurol       Date:  2008-08       Impact factor: 3.372

9.  Impairment in Guillain-Barré syndrome during the first 2 years after onset: a prospective study.

Authors:  Anette Forsberg; Rayomand Press; Ulrika Einarsson; Jésus de Pedro-Cuesta; Lotta Widén Holmqvist
Journal:  J Neurol Sci       Date:  2004-12-15       Impact factor: 3.181

10.  Unusual clinical variants and signs in Guillain-Barré syndrome.

Authors:  A H Ropper
Journal:  Arch Neurol       Date:  1986-11
View more
  4 in total

1.  Guillain-Barré syndrome and posterior reversible leukoencephalopathy syndrome: a rare association.

Authors:  Stuti Joshi; David Prentice; Jolandi van Heerden; Thomas Chemmanam
Journal:  BMJ Case Rep       Date:  2020-04-20

2.  Severe Headache, Paraesthesias, Facial Diplegia and Pleocytosis: A Misleading Presentation of Guillain-Barré Syndrome.

Authors:  Mohamed Reda Belkhribchia; Abderrahim Chekabab; Yahya Naji; Latifa Hadrane; Soufiane Hassar; Nissrine Louhab; Najib Kissani
Journal:  Eur J Case Rep Intern Med       Date:  2021-01-29

3.  Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome.

Authors:  Christina Doxaki; Eleftheria Papadopoulou; Iliana Maniadaki; Nikolaos G Tsakalis; Konstantinos Palikaras; Pelagia Vorgia
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

4.  Pain drawings as a diagnostic tool for the differentiation between two pain-associated rare diseases (Ehlers-Danlos-Syndrome, Guillain-Barré-Syndrome).

Authors:  Larissa Wester; Martin Mücke; Tim Theodor Albert Bender; Julia Sellin; Frank Klawonn; Rupert Conrad; Natasza Szczypien
Journal:  Orphanet J Rare Dis       Date:  2020-11-17       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.